These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 31054541)
1. In-Silico analysis of missense SNPs in Human HPPD gene associated with Tyrosinemia type III and Hawkinsinuria. Naveed M; Tehreem S; Mehboob MZ Comput Biol Chem; 2019 Jun; 80():284-291. PubMed ID: 31054541 [TBL] [Abstract][Full Text] [Related]
2. Mutations in the 4-hydroxyphenylpyruvic acid dioxygenase gene are responsible for tyrosinemia type III and hawkinsinuria. Tomoeda K; Awata H; Matsuura T; Matsuda I; Ploechl E; Milovac T; Boneh A; Scott CR; Danks DM; Endo F Mol Genet Metab; 2000 Nov; 71(3):506-10. PubMed ID: 11073718 [TBL] [Abstract][Full Text] [Related]
3. Manifestation of hawkinsinuria in a patient compound heterozygous for hawkinsinuria and tyrosinemia III. Item CB; Mihalek I; Lichtarge O; Jalan A; Vodopiutz J; Muhl A; Bodamer OA Mol Genet Metab; 2007 Aug; 91(4):379-83. PubMed ID: 17560158 [TBL] [Abstract][Full Text] [Related]
4. Variant analysis of HPD genes from two families showing elevated tyrosine upon newborn screening by tandem mass spectrometry (MS/MS). Zhao D; Tian Y; Li X; Ni M; Zhu X; Jia L J Pediatr Endocrinol Metab; 2020 Apr; 33(4):563-567. PubMed ID: 32109208 [TBL] [Abstract][Full Text] [Related]
5. Hawkinsinuria in two unrelated Greek newborns: identification of a novel variant, biochemical findings and treatment. Thodi G; Schulpis KH; Dotsikas Y; Pavlides C; Molou E; Chatzidaki M; Triantafylli O; Loukas YL J Pediatr Endocrinol Metab; 2016 Jan; 29(1):15-20. PubMed ID: 26226126 [TBL] [Abstract][Full Text] [Related]
6. Hawkinsinuria clinical practice guidelines: a Mexican case report and literature review. Cruz-Camino H; Vazquez-Cantu DL; Zea-Rey AV; López-Valdez J; Jiménez-Lozano J; Gómez-Gutiérrez R; Cantú-Reyna C J Int Med Res; 2020 Feb; 48(2):300060519863543. PubMed ID: 31342835 [TBL] [Abstract][Full Text] [Related]
7. Mutations in the 4-hydroxyphenylpyruvate dioxygenase gene (HPD) in patients with tyrosinemia type III. Rüetschi U; Cerone R; Pérez-Cerda C; Schiaffino MC; Standing S; Ugarte M; Holme E Hum Genet; 2000 Jun; 106(6):654-62. PubMed ID: 10942115 [TBL] [Abstract][Full Text] [Related]
8. Tyrosinemia Type III detected via neonatal screening: management and outcome. Heylen E; Scherer G; Vincent MF; Marie S; Fischer J; Nassogne MC Mol Genet Metab; 2012 Nov; 107(3):605-7. PubMed ID: 23036342 [TBL] [Abstract][Full Text] [Related]
9. Product analysis and inhibition studies of a causative Asn to Ser variant of 4-hydroxyphenylpyruvate dioxygenase suggest a simple route to the treatment of Hawkinsinuria. Brownlee JM; Heinz B; Bates J; Moran GR Biochemistry; 2010 Aug; 49(33):7218-26. PubMed ID: 20677779 [TBL] [Abstract][Full Text] [Related]
10. The mutation spectrum and ethnic distribution of non-hepatorenal tyrosinemia (types II, III). Beyzaei Z; Nabavizadeh S; Karimzadeh S; Geramizadeh B Orphanet J Rare Dis; 2022 Dec; 17(1):424. PubMed ID: 36471409 [TBL] [Abstract][Full Text] [Related]
11. In Silico Analysis of FMR1 Gene Missense SNPs. Tekcan A Cell Biochem Biophys; 2016 Jun; 74(2):109-27. PubMed ID: 26880065 [TBL] [Abstract][Full Text] [Related]
12. In silico screening and identification of deleterious missense SNPs along with their effects on CD-209 gene: An insight to CD-209 related-diseases. Kakar MU; Matloob M; Dai R; Deng Y; Ullah K; Kakar IU; Khaliq G; Umer M; Bhutto ZA; Fazlani SA; Mehboob MZ PLoS One; 2021; 16(2):e0247249. PubMed ID: 33635927 [TBL] [Abstract][Full Text] [Related]
13. Crystal structure of Pseudomonas fluorescens 4-hydroxyphenylpyruvate dioxygenase: an enzyme involved in the tyrosine degradation pathway. Serre L; Sailland A; Sy D; Boudec P; Rolland A; Pebay-Peyroula E; Cohen-Addad C Structure; 1999 Aug; 7(8):977-88. PubMed ID: 10467142 [TBL] [Abstract][Full Text] [Related]
14. In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene. Kamal MM; Mia MS; Faruque MO; Rabby MG; Islam MN; Talukder MEK; Wani TA; Rahman MA; Hasan MM Sci Rep; 2024 May; 14(1):11607. PubMed ID: 38773180 [TBL] [Abstract][Full Text] [Related]
15. Role of the N-terminus in human 4-hydroxyphenylpyruvate dioxygenase activity. Feng AN; Huang CW; Lin CH; Chang YL; Ni MY; Lee HJ J Biochem; 2020 Mar; 167(3):315-322. PubMed ID: 31722428 [TBL] [Abstract][Full Text] [Related]
17. Exploring the impact of CYP11A1's missense SNPs on the interaction between CYP11A1 and cholesterol: A comprehensive structural analysis and MD simulation study. Redouane S; Harmak H; Elkarhat Z; Charoute H; Malki A; Barakat A; Rouba H Comput Biol Chem; 2023 Oct; 106():107937. PubMed ID: 37552904 [TBL] [Abstract][Full Text] [Related]
18. The different catalytic roles of the metal-binding ligands in human 4-hydroxyphenylpyruvate dioxygenase. Huang CW; Liu HC; Shen CP; Chen YT; Lee SJ; Lloyd MD; Lee HJ Biochem J; 2016 May; 473(9):1179-89. PubMed ID: 26936969 [TBL] [Abstract][Full Text] [Related]